Pharmacotherapy 3

Subject Code : SFA-656

module description
Back to courses
Module Name Pharmacotherapy 3
Module Level, if applicable 3rd year Types of teaching and learning Teaching & Case Base Learning
Code, if applicable SFA-656 Class size 50 & 50
Semester 6th semester Attendance time (hours per week per semester) 2 h & 1h
Person responsible for the module Apt. Chynthia Pradiftha Sari, M.Sc Forms of active participation Discussion & Report
Lecturer(s) Apt. Chynthia Pradiftha Sari, M.Sc Workload Lecture: 2 (hour) x 14 (meeting) = 28

Preparation and follow up 4 (hour) x 14 (self-learning) = 56

Attendance time 1 (hour) x 12 (meeting) = 12

Preparation and follow up 4 (hour) x 14 (self-learning) = 24
Language English- Indonesia Total workload 120 hours
Relation to curriculum Compulsory course Credit points 3 CU
Requirements according to examination regulations Minimum attendance at lectures is 75% (according to UII regulation). Final score is evaluated based on assignment and reports (40%), mid semester exam (30%), and end semester exam (30%).
Recommended prerequisites Pharmacology
Related course –
Study and examination requirements and forms of examination Mid-term, Final term, and Presentation

By the end of this course students should be able to:

  • Students will be able to assess and evaluate a pharmacotherapy from the patient with gastrointestinal disorder, ophthalmic disorder, and respiratory disorder.

The course will cover the pathophysiology, therapeutic management (pharmacological and non-pharmacological) and pharmacy practice issues in the management of patients with a range of disorders including:

  • Constipation
  • Diarrhea
  • Peptic ulcer disease
  • Nausea and vomiting
  • Hepatitis
  • Cirrhosis
  • Rhinitis
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Glaucoma

Text books, slides (power points), and video

  • Brunton, L., Chabner B., Knoliman B, 2011, Godman and Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill
  • Dipiro, JT., Talbert, RL., Yee., et al., 2017, Pharmacotherapy; a pathophysiologic approach, 10th ed, McGrawn-Hill
  • GINA (Global Initiative for Asthma)
  • GOLD (Global Initiative for Chronic Obstructive Lung Disease)
  • www.cochrane.org
  • www.nejm.com
  • www.bmj.com